Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Clinical trial NCT02948829 · COMPLETED

Trial details

NCT number: NCT02948829
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2017-04-03
Primary completion: 2017-10-16
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.